MA49956B1 - Composés de pyrimidine utilisés en tant qu'inhibiteurs de kinase jak - Google Patents
Composés de pyrimidine utilisés en tant qu'inhibiteurs de kinase jakInfo
- Publication number
- MA49956B1 MA49956B1 MA49956A MA49956A MA49956B1 MA 49956 B1 MA49956 B1 MA 49956B1 MA 49956 A MA49956 A MA 49956A MA 49956 A MA49956 A MA 49956A MA 49956 B1 MA49956 B1 MA 49956B1
- Authority
- MA
- Morocco
- Prior art keywords
- kinase inhibitors
- compounds used
- pyrimidine compounds
- jak kinase
- compounds
- Prior art date
Links
- 229940043355 kinase inhibitor Drugs 0.000 title 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 title 1
- 150000003230 pyrimidines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 201000004624 Dermatitis Diseases 0.000 abstract 1
- 108091000080 Phosphotransferase Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000020233 phosphotransferase Human genes 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Abstract
L'invention concerne un composé de formule (i) : (formule (i)) ou un sel pharmaceutiquement acceptable de celui-ci, qui est utile en tant qu'inhibiteur de kinases jak. La présente invention concerne également des compositions pharmaceutiques comprenant de tels composés, une forme cristalline, des procédés d'utilisation de ces composés pour traiter des maladies cutanées inflammatoires et d'autres maladies, et des procédés et intermédiaires utiles dans la préparation de tels composés.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762577852P | 2017-10-27 | 2017-10-27 | |
PCT/US2018/057682 WO2019084383A1 (fr) | 2017-10-27 | 2018-10-26 | Composés de pyrimidine utilisés en tant qu'inhibiteurs de kinase jak |
Publications (2)
Publication Number | Publication Date |
---|---|
MA49956A MA49956A (fr) | 2020-07-01 |
MA49956B1 true MA49956B1 (fr) | 2022-11-30 |
Family
ID=64277858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA49956A MA49956B1 (fr) | 2017-10-27 | 2018-10-26 | Composés de pyrimidine utilisés en tant qu'inhibiteurs de kinase jak |
Country Status (37)
Country | Link |
---|---|
US (6) | US10308646B2 (fr) |
EP (1) | EP3672965B1 (fr) |
JP (1) | JP7218364B2 (fr) |
KR (1) | KR102613503B1 (fr) |
CN (1) | CN111247142B (fr) |
AR (1) | AR113803A1 (fr) |
AU (1) | AU2018354370B2 (fr) |
BR (1) | BR112020008015A2 (fr) |
CA (1) | CA3074034A1 (fr) |
CL (1) | CL2020001090A1 (fr) |
CR (1) | CR20200180A (fr) |
CU (1) | CU24671B1 (fr) |
DK (1) | DK3672965T3 (fr) |
DO (1) | DOP2020000083A (fr) |
EA (1) | EA202091016A1 (fr) |
EC (1) | ECSP20023795A (fr) |
ES (1) | ES2932526T3 (fr) |
GE (1) | GEP20227344B (fr) |
HR (1) | HRP20221221T1 (fr) |
HU (1) | HUE060401T2 (fr) |
IL (1) | IL274037B2 (fr) |
LT (1) | LT3672965T (fr) |
MA (1) | MA49956B1 (fr) |
MD (1) | MD3672965T2 (fr) |
MX (1) | MX2020004255A (fr) |
NI (1) | NI202000032A (fr) |
PE (1) | PE20201495A1 (fr) |
PH (1) | PH12020500528A1 (fr) |
PL (1) | PL3672965T3 (fr) |
PT (1) | PT3672965T (fr) |
RS (1) | RS63608B1 (fr) |
SG (1) | SG11202001706RA (fr) |
SI (1) | SI3672965T1 (fr) |
TW (1) | TWI789446B (fr) |
UA (1) | UA125130C2 (fr) |
WO (1) | WO2019084383A1 (fr) |
ZA (1) | ZA202001641B (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7218364B2 (ja) | 2017-10-27 | 2023-02-06 | セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー | Jakキナーゼ阻害剤としてのピリミジン化合物 |
TWI741423B (zh) * | 2018-11-30 | 2021-10-01 | 大陸商江蘇豪森藥業集團有限公司 | 雜芳類衍生物調節劑、其製備方法和應用 |
US11439641B2 (en) | 2019-04-24 | 2022-09-13 | Theravance Biopharma R&D Ip, Llc | Pyrimidine JAK inhibitors for the treatment of skin diseases |
AR118768A1 (es) | 2019-04-24 | 2021-10-27 | Theravance Biopharma R&D Ip Llc | Derivados de pirimidina como inhibidores de las cinasas jak |
IL300006A (en) * | 2020-07-28 | 2023-03-01 | Arcutis Biotherapeutics Inc | A formulation for external use containing a JAK inhibitor and Orat-4 |
KR20230074733A (ko) * | 2020-08-26 | 2023-05-31 | 날로 테라퓨틱스 | Myc 패밀리 원종양유전자 단백질의 조정제 |
EP4225438A1 (fr) * | 2020-10-08 | 2023-08-16 | Icahn School of Medicine at Mount Sinai | Compositions pour le traitement de l'alopécie aréata, biomarqueurs pour le succès du traitement, et leurs méthodes d'utilisation |
WO2023076161A1 (fr) | 2021-10-25 | 2023-05-04 | Kymera Therapeutics, Inc. | Agents de dégradation de tyk2 et leurs utilisations |
CN114246938A (zh) * | 2022-01-25 | 2022-03-29 | 中山大学中山眼科中心 | Il-4在制备用于治疗视网膜变性疾病药物中的应用 |
CN115487301B (zh) * | 2022-11-08 | 2023-07-07 | 四川大学华西医院 | Il-13抑制剂在制备延缓或治疗视网膜色素变性的药物中的用途 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4919934A (en) | 1989-03-02 | 1990-04-24 | Richardson-Vicks Inc. | Cosmetic sticks |
AU2001292670A1 (en) | 2000-09-15 | 2002-03-26 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
US6660731B2 (en) | 2000-09-15 | 2003-12-09 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
BR0116411A (pt) | 2000-12-21 | 2003-11-11 | Vertex Pharma | Compostos de pirazol úteis como inibidores de proteìna cinase |
CA2588220A1 (fr) | 2004-12-23 | 2006-06-29 | Pfizer Products Inc. | Derives heteroaromatiques utiles en tant qu'agents anticancereux |
CA2629781A1 (fr) | 2005-11-16 | 2007-05-24 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines utiles en tant qu'inhibiteurs de la kinase |
AU2007263655A1 (en) | 2006-06-30 | 2008-01-03 | Astrazeneca Ab | Pyrimidine derivatives useful in the treatment of cancer |
US8222256B2 (en) | 2006-07-05 | 2012-07-17 | Exelixis, Inc. | Methods of using IGFIR and ABL kinase modulators |
CN104011050A (zh) | 2011-12-22 | 2014-08-27 | 霍夫曼-拉罗奇有限公司 | 作为丝氨酸/苏氨酸激酶抑制剂的2,4-二氨基-嘧啶衍生物 |
WO2015094803A1 (fr) | 2013-12-16 | 2015-06-25 | Calitor Sciences, Llc | Composés hétéroaryles substitués et méthodes d'utilisation |
NO2721710T3 (fr) | 2014-08-21 | 2018-03-31 | ||
CN106687467A (zh) * | 2014-09-30 | 2017-05-17 | 韩美精密化学株式会社 | 高纯度(r)‑9‑[2‑(磷酰甲氧基)丙基]腺嘌呤的制备方法 |
PT3303348T (pt) * | 2015-05-28 | 2019-11-15 | Theravance Biopharma R&D Ip Llc | Compostos de naftiridina como inibidores da jak cinase |
WO2017044434A1 (fr) | 2015-09-11 | 2017-03-16 | Sunshine Lake Pharma Co., Ltd. | Composés hétéroaryle substitués et leurs méthodes d'utilisation |
US10028960B2 (en) | 2016-04-28 | 2018-07-24 | Theravance Biopharma R&D Ip, Llc | Pyrimidine compounds as JAK kinase inhibitors |
JP7218364B2 (ja) * | 2017-10-27 | 2023-02-06 | セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー | Jakキナーゼ阻害剤としてのピリミジン化合物 |
US11439641B2 (en) | 2019-04-24 | 2022-09-13 | Theravance Biopharma R&D Ip, Llc | Pyrimidine JAK inhibitors for the treatment of skin diseases |
AR118768A1 (es) | 2019-04-24 | 2021-10-27 | Theravance Biopharma R&D Ip Llc | Derivados de pirimidina como inhibidores de las cinasas jak |
-
2018
- 2018-10-26 JP JP2020523324A patent/JP7218364B2/ja active Active
- 2018-10-26 CU CU2020000053A patent/CU24671B1/es unknown
- 2018-10-26 SI SI201830770T patent/SI3672965T1/sl unknown
- 2018-10-26 DK DK18801171.2T patent/DK3672965T3/da active
- 2018-10-26 EA EA202091016A patent/EA202091016A1/ru unknown
- 2018-10-26 PT PT188011712T patent/PT3672965T/pt unknown
- 2018-10-26 CN CN201880068081.5A patent/CN111247142B/zh active Active
- 2018-10-26 CR CR20200180A patent/CR20200180A/es unknown
- 2018-10-26 EP EP18801171.2A patent/EP3672965B1/fr active Active
- 2018-10-26 SG SG11202001706RA patent/SG11202001706RA/en unknown
- 2018-10-26 US US16/171,693 patent/US10308646B2/en active Active
- 2018-10-26 ES ES18801171T patent/ES2932526T3/es active Active
- 2018-10-26 IL IL274037A patent/IL274037B2/en unknown
- 2018-10-26 MX MX2020004255A patent/MX2020004255A/es unknown
- 2018-10-26 AU AU2018354370A patent/AU2018354370B2/en active Active
- 2018-10-26 PL PL18801171.2T patent/PL3672965T3/pl unknown
- 2018-10-26 WO PCT/US2018/057682 patent/WO2019084383A1/fr unknown
- 2018-10-26 MA MA49956A patent/MA49956B1/fr unknown
- 2018-10-26 MD MDE20200681T patent/MD3672965T2/ro unknown
- 2018-10-26 HU HUE18801171A patent/HUE060401T2/hu unknown
- 2018-10-26 KR KR1020207012597A patent/KR102613503B1/ko active IP Right Grant
- 2018-10-26 HR HRP20221221TT patent/HRP20221221T1/hr unknown
- 2018-10-26 UA UAA202003146A patent/UA125130C2/uk unknown
- 2018-10-26 PE PE2020000414A patent/PE20201495A1/es unknown
- 2018-10-26 TW TW107137865A patent/TWI789446B/zh active
- 2018-10-26 RS RS20220903A patent/RS63608B1/sr unknown
- 2018-10-26 LT LTEPPCT/US2018/057682T patent/LT3672965T/lt unknown
- 2018-10-26 AR ARP180103131A patent/AR113803A1/es unknown
- 2018-10-26 GE GEAP201815340A patent/GEP20227344B/en unknown
- 2018-10-26 BR BR112020008015-2A patent/BR112020008015A2/pt unknown
- 2018-10-26 CA CA3074034A patent/CA3074034A1/fr active Pending
-
2019
- 2019-04-22 US US16/390,175 patent/US10562894B2/en active Active
-
2020
- 2020-01-08 US US16/737,067 patent/US10774080B2/en active Active
- 2020-03-13 PH PH12020500528A patent/PH12020500528A1/en unknown
- 2020-03-16 ZA ZA2020/01641A patent/ZA202001641B/en unknown
- 2020-04-23 CL CL2020001090A patent/CL2020001090A1/es unknown
- 2020-04-24 NI NI202000032A patent/NI202000032A/es unknown
- 2020-04-27 EC ECSENADI202023795A patent/ECSP20023795A/es unknown
- 2020-05-06 DO DO2020000083A patent/DOP2020000083A/es unknown
- 2020-08-12 US US16/991,268 patent/US10988470B2/en active Active
-
2021
- 2021-03-30 US US17/301,243 patent/US11420965B2/en active Active
-
2022
- 2022-06-30 US US17/855,539 patent/US11814377B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA49956B1 (fr) | Composés de pyrimidine utilisés en tant qu'inhibiteurs de kinase jak | |
MA47970B1 (fr) | Composé inhibiteur de jak à base d'imidazo-pipéridine fusionnée | |
MA43979B1 (fr) | Dérivés de 1h-indazole-3-carboxamide et composés similaires en tant qu'inhibiteurs du facteur d pour le traitement de maladies characterisés par une activité aberrante du système complémentaire, comme p.E. Troubles immunologiques | |
GEP20237561B (en) | Protein tyrosine phosphatase inhibitors | |
MA41134B1 (fr) | Composés substitués de 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione pour le traitement et la prophylaxie des infections virales | |
MA40111A1 (fr) | Dérivés du tétrahydronaphtalène inhibant la protéine mcl-1 | |
MA38380A1 (fr) | Inhibiteurs quinazoline de l'activation des formes mutantes du récepteur de croissance épidermique (egfr) | |
MA53399B1 (fr) | Pyrazoles substitués en tant qu`inhibiteurs de la kallicréine plasmatique humaine | |
MA41179A (fr) | Composés inhibiteurs de parg | |
MA37866B1 (fr) | Dérivés de type aza-indazole ou diaza-indazole pour le traitement de la douleur | |
MA34903B1 (fr) | Derives de type azaindazole ou diazaindazole utilises comme medicaments | |
TW200618804A (en) | Phosphonate analogs of HIV inhibitor compounds | |
MA37762A1 (fr) | Composés n-aryltriazole utilisés comme antagonistes de lpar | |
MA37764A1 (fr) | Composés n-alkyltriazole utilisés comme antagonistes de lpar | |
MA46229B1 (fr) | Composés d'hétéroaryle carboxamide en tant qu'inhibiteurs de ripk2 | |
MA40955A (fr) | 2-amino-6-(difluorométhyl)-5,5-difluoro-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1 | |
MA49127B1 (fr) | Dérivés d'indole n-substitués | |
MA37765A1 (fr) | Composés de pyrazole substitués utilisés comme antagonistes de lpar | |
MA43052B1 (fr) | Inhibiteurs de la kallicréine plasmatique humaine | |
MX2020001531A (es) | Nuevos compuestos hetorociclicos como inhibidores de cdk8/19. | |
UA103329C2 (ru) | Соли соединений-ингибиторов вич | |
WO2020247298A3 (fr) | Dérivés d'indazole 5 -, 6-disubstitués, 1-pyrazolyle, en tant qu'inhibiteurs de lrrk2, compositions pharmaceutiques et utilisations correspondantes | |
MA43913B1 (fr) | Modulateurs allostériques positifs du récepteur m1 muscarinique | |
EA202092253A1 (ru) | Замещенные производные имидазолидин-2-она в качестве ингибиторов prmt5 | |
MY195576A (en) | Novel Amino-Imidazopyridine Derivatives as Janus Kinase Inhibitors and Pharmaceutical use Thereof |